@article {67988,
	title = {Transverse endoplasmic reticulum expansion in hereditary spastic paraplegia corticospinal axons.},
	journal = {Human Molecular Genetics},
	year = {2022},
	month = {2022 Mar 26},
	abstract = {<p>Hereditary spastic paraplegias (HSPs) comprise a large group of inherited neurologic disorders affecting the longest corticospinal axons (SPG1-86 plus others), with shared manifestations of lower extremity spasticity and gait impairment. Common autosomal dominant HSPs are caused by mutations in genes encoding the microtubule-severing ATPase spastin (SPAST; SPG4), the membrane-bound GTPase atlastin-1 (ATL1; SPG3A), and the reticulon-like, microtubule-binding protein REEP1 (REEP1; SPG31). These proteins bind one another and function in shaping the tubular endoplasmic reticulum (ER) network. Typically, mouse models of HSPs have mild, later-onset phenotypes, possibly reflecting far shorter lengths of their corticospinal axons relative to humans. Here, we have generated a robust, double mutant mouse model of HSP in which atlastin-1 is genetically modified with a K80A knock-in (KI) missense change that abolishes its GTPase activity, while its binding partner Reep1 is knocked out. Atl1KI/KI/Reep1-/- mice exhibit early-onset and rapidly progressive declines in several motor function tests. Also, ER in mutant corticospinal axons dramatically expands transversely and periodically in a mutation dosage-dependent manner to create a ladder-like appearance, based on reconstructions of focused ion beam-scanning electron microscopy datasets using machine learning-based auto-segmentation. In lockstep with changes in ER morphology, axonal mitochondria are fragmented and proportions of hypophosphorylated neurofilament H and M subunits are dramatically increased in Atl1KI/KI/Reep1-/- spinal cord. Co-occurrence of these findings links ER morphology changes to alterations in mitochondrial morphology and cytoskeletal organization. Atl1KI/KI/Reep1-/- mice represent an early-onset rodent HSP model with robust behavioral and cellular readouts for testing novel therapies.</p>
},
	issn = {1460-2083},
	doi = {10.1093/hmg/ddac072},
	author = {Zhu, Peng-Peng and Hung, Hui-Fang and Batchenkova, Natalia and Nixon-Abell, Jonathon and Henderson, James and Zheng, Pengli and Renvois{\'e}, Benoit and Pang, Song and Xu, C Shan and Saalfeld, Stephan and Funke, Jan and Xie, Yuxiang and Svara, Fabian and Hess, Harald F and Blackstone, Craig}
}
